Kasey Cheyenne Bamel, DNP

Kasey Bamel practices at UCSD Hillcrest Medical Center in San Diego, California.

Kasey Bamel's NPI, 1487106886, was assigned on November 1, 2016. Kasey Bamel holds California license 95004824.

Kasey Bamel's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Kasey Bamel's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Kasey Bamel is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Kasey Bamel to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kasey Bamel practices, 4 sites in all. Vendor and product names are available with a free account.

Family is Kasey Bamel's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Kasey Bamel is licensed in California.

Dmand AI lists contact dermatitis among the conditions Kasey Bamel treats.

CMS data shows 53 Medicare services from Kasey Bamel across 3 procedure codes in 2024, for 53 Medicare patients. Medicare paid $3,011 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 53 Medicare patients who saw Kasey Bamel in 2024. The largest group is 65 to 74, with 26 patients. 72% of them have high blood pressure, and 66% have high cholesterol. 34% are also on Medicaid. Their average risk score is 2.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kasey Bamel's median patient age at 65, with 52% women.

In 2024, Kasey Bamel wrote 337 Medicare Part D claims for 67 patients. 83% of them were for generic drugs. CMS names the drug for 167 of them, across 10 drugs with 11 or more claims each, at $191,650 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Kasey Bamel for performance year 2024, reported as part of a group. Kasey Bamel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Kasey Bamel as offering telehealth.

CMS Open Payments shows 23 general payments to Kasey Bamel from 8 drug and device companies from 2024 to 2025. Speaker and faculty fees make up the largest share, 66% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $6,289.